Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas

Pituitary Macroadenoma Clinical Trial

Official title:
A Single-center, Prospective, Randomized Controlled Trial Investigating the Utility if Intraoperative MRI in Transphenoidal Pituitary Surgery Off Macroadenomas.

Status Terminated

Clinical Trial Summary

The investigators are studying the utility of intra-operative magnetic resonance imaging (iMRI) during transsphenoidal pituitary surgery for large macroadenomas by randomizing patients to either an intra-operative MRI after resection, or no intra-operative MRI. The investigators will then count the number of gross total resection in each group of patients and also the complications related to surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02396810
Study type	Interventional
Source	Dartmouth-Hitchcock Medical Center
Contact
Status	Terminated
Phase	N/A
Start date	May 19, 2015
Completion date	July 1, 2023

View Details

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT01444209` - Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas	Phase 2
	Completed	`NCT04212793` - Detection of PitNET Tissue During TSS Using Bevacizumab-800CW	Phase 1